Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
Conditions
Hemophilia A
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sobi Investigational Site, Zagreb, Croatia
Sobi Investigational Site, Brno, Czechia
Sobi Investigational Site, Ostrava, Czechia
Sobi Investigational Site, Prague, Czechia
Sobi Investigational Site, Bordeaux, France
Sobi Investigational Site, Marseille, France
Sobi Investigational Site, Montpellier, France
Sobi Investigational Site, Nantes, France
Sobi Investigational Site, Paris, France
Sobi Investigational Site, Rennes, France
Sobi Investigational Site, Rouen, France
Sobi Investigational Site, Berlin, Germany
Sobi Investigational Site, Bonn, Germany
Sobi Investigational Site, Frankfurt am Main, Germany
Sobi Investigational Site, Hamburg, Germany
Sobi Investigational Site, Munich, Germany
Sobi Investigational Site, Dublin, Ireland
Sobi Investigational Site, Catania, Italy
Sobi Investigational Site, Padua, Italy
Sobi Investigational Site, Turin, Italy
Sobi Investigational Site, A Coruña, Spain
Sobi Investigational Site, Barcelona, Spain
Sobi Investigational Site, Málaga, Spain
Sobi Investigational Site, Palma de Mallorca, Spain
Sobi Investigational Site, Zaragoza, Spain
Sobi Investigational Site, Birmingham, United Kingdom
Sobi Investigational Site, Cardiff, United Kingdom
Sobi Investigational Site, London, United Kingdom
Sobi Investigational Site, Manchester, United Kingdom
Study leads
Study Physician
Study Director
Swedish Orphan Biovitrum AB (publ)